Conditioning

7 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(3)

Drug	Company
busulfan	Amneal Pharmaceuticals, Inc. (AMRX)
busulfan	NEXUS BIOPHARMA INC (NEXS)
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)

Preclinical(3)

Drug	Company
fsi-174	Forty Seven, Inc. (FTSV)
fsi-189	Forty Seven, Inc. (FTSV)
Iomab-ACT	Actinium Pharmaceuticals, Inc. (ATNM)

Phase 2/Phase 3(1)

Drug	Company
Iomab-B	Actinium Pharmaceuticals, Inc. (ATNM)

BioSniper tracks 7 drugs in development for Conditioning across 5 companies.

There are 1 clinical trial targeting Conditioning tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.